Rituximab-induced elimination of acquired angioedema due to C1-inhibitor deficiency.
Levi
Marcel
M
Hack
C Erik
CE
van Oers
Marinus H
MH
D000368:Aged; D000799:Angioedema / Q000150:complications / Q000188:drug therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D050718:Complement C1 Inhibitor Protein / Q000378:metabolism*; D005260:Female; D006801:Humans; D007155:Immunologic Factors; D008297:Male; D008875:Middle Aged; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D050718:Complement C1 Inhibitor Protein; D007155:Immunologic Factors; D000069283:Rituximab